Literature DB >> 10817232

An evaluation of the in vitro activity of terbinafine.

C J Jessup1, N S Ryder, M A Ghannoum.   

Abstract

Terbinafine has previously been shown to be highly active against dermatophytes and many other filamentous fungi. However, its activity against yeasts is controversial, with earlier reports suggesting that it has low activity, while more recent studies demonstrated that terbinafine is effective against yeasts. In this study, the in vitro activity of terbinafine was evaluated against a broad range of fungal isolates. We examined the susceptibility of 100 yeast strains (10 species including Candida albicans, non-C. albicans, fluconazole-susceptible and -resistant candidal strains), and 184 strains of filamentous fungi and dermatophytes (29 species including Aspergillus, Fusarium, Sporothrix, Trichophyton rubrum, T. mentagrophytes, T. tonsurans, Microsporum canis and Epidermophyton floccosum), using the NCCLS M27-A microdilution methodology for yeasts and a modified M38-P methodology for moulds. The endpoint for terbinafine was defined as 80% inhibition compared with the growth control well. The mean yeast and filamentous fungi minimum inhibitory concentration values +/- SEM (in microg ml(-1)) for terbinafine were: 6.60 +/- 0.73 and 1.04 +/- 0.28, respectively. In conclusion, our data suggest that terbinafine, in addition to its potent activity against dermatophytes, is considerably effective against a broad range of yeasts and filamentous fungi in vitro. Therefore, investigations concerning its antifungal activity in vivo against such organisms should be pursued.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10817232     DOI: 10.1080/mmy.38.2.155.159

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  23 in total

Review 1.  Antifungal susceptibility testing: practical aspects and current challenges.

Authors:  J H Rex; M A Pfaller; T J Walsh; V Chaturvedi; A Espinel-Ingroff; M A Ghannoum; L L Gosey; F C Odds; M G Rinaldi; D J Sheehan; D W Warnock
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B.

Authors:  C B Moore; C M Walls; D W Denning
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  In vitro susceptibilities of zygomycetes to combinations of antimicrobial agents.

Authors:  Eric Dannaoui; Javier Afeltra; Jacques F G M Meis; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

4.  Comparison of in vitro activities of 17 antifungal drugs against a panel of 20 dermatophytes by using a microdilution assay.

Authors:  Bertrand Favre; Bettina Hofbauer; Kwang-Soo Hildering; Neil S Ryder
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

5.  Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine.

Authors:  Pranab K Mukherjee; Steven D Leidich; Nancy Isham; Ingrid Leitner; Neil S Ryder; Mahmoud A Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

6.  In vitro antifungal susceptibilities of uncommon basidiomycetous yeasts.

Authors:  Carolina Serena; Francisco Javier Pastor; Montserrat Ortoneda; Javier Capilla; Nicole Nolard; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

7.  In vitro susceptibilities of isolates of Sporothrix schenckii to itraconazole and terbinafine.

Authors:  Lidiane Meire Kohler; Paulo César Fialho Monteiro; Rosane Christine Hahn; Júnia Soares Hamdan
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

8.  Molecular identification and in vitro response to antifungal drugs of clinical isolates of Exserohilum.

Authors:  Keith Cássia da Cunha; Deanna A Sutton; Josepa Gené; Javier Capilla; Josep Cano; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2012-06-25       Impact factor: 5.191

9.  In vitro activities of terbinafine in combination with fluconazole, itraconazole, voriconazole, and posaconazole against clinical isolates of Candida glabrata with decreased susceptibility to azoles.

Authors:  Sofia Perea; Gloria Gonzalez; Annette W Fothergill; Deanna A Sutton; Michael G Rinaldi
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

10.  In vitro comparison of activities of terbinafine and itraconazole against Paracoccidioides brasiliensis.

Authors:  R C Hahn; C J F Fontes; R D Batista; J S Hamdan
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.